Reach Us +44-1647-403003
The Expression Of Synaptonemal Complex Protein 3 (SCP3) And Phospho-akt In Cervical Neoplasias | 5254
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

The expression of synaptonemal complex protein 3 (SCP3) and phospho-akt in cervical neoplasias

International Conference & Exhibition on Cell Science & Stem Cell Research

H. Cho, S.Y. Kim, E.J. Nam, S.W. Kim, S. Kim, J.H. Kim and Y.T. Kim

Posters: J Cell Sci Ther

DOI: 10.4172/2157-7013.S1.15

Purpose: Synaptonemal complex protein 3 (SCP3) is a marker for cell transformation, and it has been shown that the overexpression of SCP3 in tumor cells could lead to activation of AKT. Th is study explored expression of SCP3 and its relationship with the phosphorylated AKT (p-AKT) in cervical neoplasias. Materials and Methods: Five hundred seven cervical tumor samples and matched normal epithelial samples were arrayed into tissue microarrays. Th e status of SCP3 and p-AKT was studied using immunohistochemical analysis. Staining results for each antibody were compared with clinical and pathologic features, and the relationship between staining results was explored. Results: Expressions of SCP3 and p-AKT were signifi cantly increased in cervical cancer cases compared with normal epitheliums (P < 0.001, each). Increased SCP3 expression was observed in patients with increasing tumor stage (P = 0.002) and tumor grade (P < 0.001). In multivariate analysis, disease-free survival in cervical cancer patients was signifi cantly shorter in cases with overexpression of SCP3 (HR = 4.81 [1.37-16.95], P = 0.014), lymph node metastases (HR = 3.07 [1.23-7.67], P = 0.016), and advanced tumor stage (HR = 2.74 [1.09-6.88], P = 0.032). SCP3+/p-AKT+ expression (P =0.034) and increased tumor stage (P = 0.006) showed shorter overall survival by Kaplan-Meier analysis. Conclusions: Th is study shows that SCP3 expression in addition to p-AKT predicts poor prognosis in cervical cancer. Moreover, the correlation between expressions of SCP3 with p-AKT indicates that SCP3 activation through the AKT pathway plays an important role in the progression of cervical cancer. cervical cancer; tissue microarray; immunohistochemistry; SCP3; AKT pathway
Relevant Topics